Atlas Venture Life Science Advisors, LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$738.6B
Holdings
16
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KYMRKymera Therapeutics, Inc. | 5,858,262 | $173.6B | 23.50% | |
| 2 | DYNDyne Therapeutics, Inc. | 9,885,449 | $113.9B | 15.42% | |
| 3 | DAWNDay One Biopharmaceuticals, Inc. | 7,608,394 | $101.7B | 13.77% | |
| 4 | IRONDisc Medicine, Inc. | 3,461,784 | $73.4B | 9.93% | |
| 5 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $57.1B | 7.74% | |
| 6 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $44.9B | 6.08% | |
| 7 | AVTEAerovate Therapeutics, Inc. | 2,039,249 | $41.1B | 5.57% | |
| 8 | REPLReplimune Group, Inc. | 2,098,300 | $37.1B | 5.02% | |
| 9 | GBIOGBXGeneration Bio, Co. | 8,279,484 | $35.6B | 4.82% | |
| 10 | AKROAkero Therapeutics, Inc. | 594,251 | $22.7B | 3.08% | |
| 11 | —Ikena Oncology, Inc. | 5,018,178 | $17.3B | 2.34% | |
| 12 | XLOXilio Therapeutics, Inc. | 2,759,344 | $8.7B | 1.18% | |
| 13 | —AvroBio, Inc. | 4,541,381 | $4.5B | 0.61% | |
| 14 | —Magenta Therapeutics, Inc. | 3,791,698 | $3.0B | 0.41% | |
| 15 | VRDNViridian Therapeutics, Inc. | 90,072 | $2.3B | 0.31% | |
| 16 | SPROSpero Therapeutics, Inc. | 1,031,160 | $1.5B | 0.20% |